Fate Therapeutics, Inc.
US ˙ NasdaqGM ˙ US31189P1021

SecurityFATE / Fate Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,821,715 shares
Latest Disclosed Value $ 2,186,058
UBS Group AG reports 351.45% increase in ownership of FATE / Fate Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,821,715 shares of Fate Therapeutics, Inc. (US:FATE) valued at $2,186,058 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 403,524 shares of Fate Therapeutics, Inc.. This represents a change in shares of 351.45% during the quarter. The current value of the position is $3,597,887 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F FATE THERAPEUTICS COM 31189P102 1,821,715 1,418,191 351.45 2,186 452.02 0.0003
2026-01-29 2025-12-31 13F FATE THERAPEUTICS COM 31189P102 403,524 88,765 28.20 397 0.00 0.0001
2025-11-13 2025-09-30 13F FATE THERAPEUTICS COM 31189P102 314,759 -647,913 -67.30 397 -63.27 0.0001
2025-08-14 2025-06-30 13F FATE THERAPEUTICS COM 31189P102 962,672 -588,409 -37.94 1,078 -12.00 0.0002
2025-05-13 2025-03-31 13F FATE THERAPEUTICS COM 31189P102 1,551,081 447,688 40.57 1,225 -32.69 0.0002
2025-02-14 2024-12-31 13F FATE THERAPEUTICS COM 31189P102 1,103,393 699,114 172.93 1,821 28.71 0.0003
2024-11-14 2024-09-30 13F FATE THERAPEUTICS COM 31189P102 404,279 239,923 145.98 1,415 162.34 0.0003
2024-08-14 2024-06-30 13F FATE THERAPEUTICS COM 31189P102 164,356 -279,694 -62.99 539 -83.46 0.0001
2024-05-13 2024-03-31 13F FATE THERAPEUTICS COM 31189P102 444,050 267,745 151.86 3,259 394.54 0.0008
2024-02-09 2023-12-31 13F FATE THERAPEUTICS COM 31189P102 176,305 109,595 164.29 659 367.38 0.0002
2023-11-09 2023-09-30 13F FATE THERAPEUTICS COM 31189P102 66,710 -192,976 -74.31 141 -88.59 0.0000
2023-08-11 2023-06-30 13F FATE THERAPEUTICS COM 31189P102 259,686 -158,440 -37.89 1,236 -48.13 0.0004
2023-05-12 2023-03-31 13F FATE THERAPEUTICS COM 31189P102 418,126 126,215 43.24 2,383 -19.08 0.0009
2023-02-08 2022-12-31 13F FATE THERAPEUTICS COM 31189P102 291,911 289,546 12,242.96 2,945 5,456.60 0.0011
2022-11-10 2022-09-30 13F FATE THERAPEUTICS COM 31189P102 2,365 -50,123 -95.49 53 -95.92 0.0000
2022-08-10 2022-06-30 13F FATE THERAPEUTICS COM 31189P102 52,488 -87,025 -62.38 1,300 -75.97 0.0005
2022-05-16 2022-03-31 13F FATE THERAPEUTICS COM 31189P102 139,513 11,513 8.99 5,409 -27.78 0.0018
2022-02-14 2021-12-31 13F FATE THERAPEUTICS COM 31189P102 128,000 101,515 383.29 7,490 377.07 0.0021
2021-11-15 2021-09-30 13F FATE THERAPEUTICS COM 31189P102 26,485 10,877 69.69 1,570 15.95 0.0005
2021-08-13 2021-06-30 13F FATE THERAPEUTICS COM 31189P102 15,608 -29,388 -65.31 1,354 -63.50 0.0004
2021-05-12 2021-03-31 13F FATE THERAPEUTICS COM 31189P102 44,996 -42,725 -48.71 3,710 -53.49 0.0012
2021-02-11 2020-12-31 13F FATE THERAPEUTICS COM 31189P102 87,721 80,793 1,166.18 7,977 2,779.78 0.0027
2020-11-12 2020-09-30 13F FATE THERAPEUTICS COM 31189P102 6,928 1,717 32.95 277 54.75 0.0001
2020-07-31 2020-06-30 13F FATE THERAPEUTICS COM 31189P102 5,211 -1,827 -25.96 179 14.74 0.0001
2020-05-01 2020-03-31 13F FATE THERAPEUTICS COM 31189P102 7,038 -44,684 -86.39 156 -84.58 0.0001
2020-02-14 2019-12-31 13F FATE THERAPEUTICS COM 31189P102 51,722 -119,783 -69.84 1,012 -62.01 0.0004
2019-11-14 2019-09-30 13F FATE THERAPEUTICS COM 31189P102 171,505 133,074 346.27 2,664 241.54 0.0010
2019-08-14 2019-06-30 13F FATE THERAPEUTICS COM 31189P102 38,431 28,877 302.25 780 364.29 0.0003
2019-05-14 2019-03-31 13F FATE THERAPEUTICS COM 31189P102 9,554 -78,398 -89.14 168 -85.12 0.0001
2019-02-14 2018-12-31 13F FATE THERAPEUTICS COM 31189P102 87,952 57,642 190.17 1,129 128.54 0.0005
2018-11-14 2018-09-30 13F FATE THERAPEUTICS COM 31189P102 30,310 -71,100 -70.11 494 -57.04 0.0002
2018-08-14 2018-06-30 13F FATE THERAPEUTICS COM 31189P102 101,410 92,252 1,007.34 1,150 1,192.13 0.0005
2018-05-15 2018-03-31 13F FATE THERAPEUTICS COM 31189P102 9,158 3,116 51.57 89 140.54 0.0000
2018-02-14 2017-12-31 13F FATE THERAPEUTICS COM 31189P102 6,042 4,292 245.26 37 428.57 0.0000
2017-11-14 2017-09-30 13F FATE THERAPEUTICS COM 31189P102 1,750 -41,875 -95.99 7 -95.04 0.0000
2017-11-14 2017-06-30 13F/A-1 FATE THERAPEUTICS COM 31189P102 43,625 43,625 141 0.0001
2017-08-14 2017-06-30 13F FATE THERAPEUTICS COM 31189P102 43,625 43,625 141
2017-11-14 2017-03-31 13F/A-1 FATE THERAPEUTICS COM 31189P102 0 -738 -100.00 0 -100.00
2017-02-14 2016-12-31 13F FATE THERAPEUTICS COM 31189P102 738 -1,537 -67.56 2 -71.43 0.0000
2016-11-14 2016-09-30 13F FATE THERAPEUTICS COM 31189P102 2,275 2,275 0.00 7 0.0000
2016-08-12 2016-06-30 13F FATE THERAPEUTICS COM 31189P102 0 -2,127 -100.00 0 -100.00
2016-05-12 2016-03-31 13F FATE THERAPEUTICS COM 31189P102 2,127 -2,103 -49.72 4 -71.43 0.0000
2016-02-16 2015-12-31 13F FATE THERAPEUTICS COM 31189P102 4,230 435 11.46 14 -30.00 0.0000
2015-11-13 2015-09-30 13F FATE THERAPEUTICS COM 31189P102 3,795 3,795 0.00 20 0.0000
2015-08-14 2015-06-30 13F FATE THERAPEUTICS COM 31189P102 0 -3,443 -100.00 0 -100.00
2015-05-14 2015-03-31 13F FATE THERAPEUTICS COM 31189P102 3,443 1,179 52.08 17 54.55 0.0000
2015-02-17 2014-12-31 13F FATE THERAPEUTICS COM 31189P102 2,264 2,264 11 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.